Biomol Ther.  2023 Jul;31(4):370-387. 10.4062/biomolther.2023.006.

Antigen Delivery Systems: Past, Present, and Future

• Ko HJ
• Kim YJ

• KMID: 2544059
• DOI: http://doi.org/10.4062/biomolther.2023.006

Abstract

The COVID-19 pandemic has increased demand for safe and effective vaccines. Research to develop vaccines against diseases including Middle East respiratory syndrome, Ebolavirus, human immunodeficiency virus, and various cancers would also contribute to global well-being. For successful vaccine development, the advancement of technologies such as antigen (Ag) screening, Ag delivery systems and adjuvants, and manufacturing processes is essential. Ag delivery systems are required not only to deliver a sufficient amount of Ag for vaccination, but also to enhance immune response. In addition, Ag types and their delivery systems determine the manufacturing processes of the vaccine product. Here, we analyze the characteristics of various Ag delivery systems: plasmids, viral vectors, bacterial vectors, nanoparticles, self-assembled particles, natural and artificial cells, and extracellular vesicles. This review provides insight into the current vaccine landscape and highlights promising avenues of research for the development and improvement of Ag delivery systems.

Keyword

Vaccine; Antigen delivery system; Vector; Nanoparticle; Self-assembled particles; Extracellular vesicle